Teaching hospital Program year 2025 Source: CMS Open Payments

Hospital of the Univ of Penna

PA

CCN 390111 CMS hospital 16769

Open in the dashboard

General payments

$2,409,886,669

4,426 payments

Research payments

$467,806,278

22,542 payments

Through program year 2025, Hospital of the Univ of Penna is reported as receiving $2,409,886,669 in general payments and $467,806,278 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $549,717,103 664
2025 Research $64,880,278 3,595
2024 General $190,029,249 716
2024 Research $68,064,140 3,512
2023 General $377,519,071 689
2023 Research $54,338,365 3,131
2022 General $726,037,667 552
2022 Research $59,363,182 3,285
2021 General $529,696,846 524
2021 Research $67,266,817 3,499
2020 General $9,331,115 541
2020 Research $89,999,121 3,126
2019 General $27,555,619 740
2019 Research $63,894,375 2,394

Breakdown

Who paid General payments · program years 2019–2025
  1. BioNTech SE $2,317,392,919 64 payments
  2. Biogen, Inc. $13,146,643 66 payments
  3. Amryt Pharma Holdings Ltd $7,971,829 17 payments
  4. Aegerion Pharmaceuticals, Inc. $7,776,854 9 payments
  5. Spark Therapeutics, Inc. $6,956,571 57 payments
  6. Chiesi USA, Inc. $5,522,318 8 payments
  7. Siemens Medical Solutions USA, Inc. $3,475,793 98 payments
  8. Merck Sharp & Dohme Corporation $2,817,160 68 payments
  9. Regeneron Pharmaceuticals, Inc. $2,633,957 50 payments
  10. Varian Medical Systems, Inc. $2,194,919 24 payments
  11. Other $39,997,705 3,965 payments
What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,368,293,820 1,010 payments
  2. Grant $17,614,048 851 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,960,397 437 payments
  4. Education $4,921,491 326 payments
  5. Consulting Fee $4,505,860 141 payments
  6. Space rental or facility fees (teaching hospital only) $4,189,467 1,192 payments
  7. Charitable Contribution $2,240,408 214 payments
  8. Long term medical supply or device loan $800,353 142 payments
  9. Gift $266,397 55 payments
  10. Debt forgiveness $68,412 46 payments
  11. Other $26,017 12 payments
Products named General payments · program years 2019–2025
  1. Comirnaty Infectious Diseases $1,600,326,779 25 payments
  2. Comirnaty Infectious Diseases $178,162,746 8 payments
  3. Juxtapid Cardiology/Vascular Diseases $7,969,829 16 payments
  4. Juxtapid Cardiology/Vascular Diseases $7,701,854 6 payments
  5. Luxturna $6,745,478 29 payments
  6. Juxtapid Homozygous Familial Hypercholesterolemia $5,522,318 8 payments
  7. ProBeam Proton Therapy System $2,458,848 13 payments
  8. Journey II $1,095,700 19 payments
  9. Proton System $851,616 4 payments
  10. Other $766,000 3 payments
  11. Other $17,677,496 2,466 payments

A payment can name more than one product, so these amounts overlap.

4,426 general · 22,542 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record